Labcorp and Epic Expand Collaboration for Lab Test Ordering
Labcorp’s full test menu is now integrated into Epic’s Aura platform, streamlining lab test ordering and results for health systems and reducing IT complexity.
Category: Company News
Company News
Latest
Company News
Latest
ClearNote Health to Present Pancreatic Cancer Test Data at DDW 2026
ClearNote Health will present data at DDW 2026 showing its Avantect Pancreatic Cancer Test achieved 82.6% sensitivity and 97.5% specificity in patients at elevated risk.
Company News
Latest
ARUP Laboratories Launches Innovation Central Laboratory for Diagnostic Development
ARUP Laboratories has opened the Innovation Central Laboratory in Salt Lake City to support biotech and pharmaceutical partners in validating technologies and accelerating diagnostic development from concept to commercialization.
QuidelOrtho Completes Acquisition of LEX Diagnostics and Molecular Testing Platform
The $100 million deal brings an ultra-fast system for respiratory viruses to QuidelOrtho’s point-of-care portfolio.
Read More
Labcorp’s FDA-Cleared Rapid Fentanyl Urine Test Launches
The FDA has cleared Labcorp’s rapid fentanyl urine test, which detects norfentanyl and delivers results in 10 minutes for use in CLIA-certified labs, according to the company’s press release.
Read More
GeneCentric Data Suggest Fragmentomics Could Expand Liquid Biopsy Beyond Mutation Testing
Presentations at AACR 2026 will showcase fragmentomics-based technology for detecting therapeutic markers and providing prognostic insight.
Read More
New Light Scattering Detector Improves Characterization of Large Molecules
The system offers faster run times and reduced sample consumption for the analysis of viral vectors, protein aggregates, and advanced materials.
Read More
Biognosys and Michael J. Fox Foundation Partner to Develop Parkinson’s Disease Biomarkers
The collaboration focuses on creating sensitive assays for a common genetic risk factor to guide drug development and clinical trials.
Read More
Thermo Fisher Scientific and PRECISE Partner on Singapore Proteomics Study
The collaboration will use multi-omic platforms and AI-driven analytics to identify disease patterns and improve patient stratification within the PRECISE-SG100K study.
Read More
Labcorp and Children’s Hospital of Philadelphia Partner to Expand Pediatric Diagnostic Access
The collaboration aims to create an innovation pipeline for specialized pediatric tests across oncology, metabolic disease, and autoimmune conditions.
Read More
Autonomous Robotic Phlebotomy Shows High Success Rates in Multicenter Trial
A multicenter trial published in Clinical Chemistry reports Vitestro’s autonomous phlebotomy system achieved a 94.5% first-stick success rate, with low hemolysis and adverse event rates, in routine clinical settings.
Read More
SPT Labtech and EMBL GeneCore Partner to Advance Automated Genomics Workflows
The collaboration focuses on implementing a liquid handling platform to streamline end-to-end laboratory processes and protocol development.
Read More
CE Mark Granted for Rapid Bacterial vs Viral Infection Test
The high-throughput host-response assay provides results in approximately 20 minutes to help guide treatment decisions and antimicrobial stewardship.
Read More
Roche Receives CE Mark for Multiple Sclerosis Blood Test
The Elecsys NfL test measures a protein associated with nerve cell injury to monitor disease activity in patients with relapsing remitting multiple sclerosis.
Read More
HNL Lab Medicine and Roche Diagnostics Form Preferred Partnership
HNL Lab Medicine has named Roche Diagnostics as a preferred partner to enhance laboratory performance, aiming to improve speed and accuracy of diagnostic results across its multi-regional network, according to the company.
Read More
GRAIL and Epic Partner to Integrate Multi-Cancer Early Detection Test into EHR
The collaboration allows clinicians to order the Galleri test and view results directly within existing electronic health record workflows.
Read More
New Billing Code Approved for Spinal Fluid Tumor Cell Test
The AMA has approved a new PLA CPT code, effective July 1, 2026, to support claims processing and clinical adoption in CNS metastases diagnostics.
Read More
CDC Awards $148 Million Contract for Emergency Diagnostic Test Development
The five-year agreement with MRIGlobal aims to enhance laboratory readiness and response for public health emergencies.
Read More